Foamix Pharmaceuticals Ltd. Severance Costs
Foamix Pharmaceuticals Ltd. reported Severance Costs of $719.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. severance costs for fiscal 2019 was $719.00K, a 21.45% increase from fiscal 2018.
- Foamix Pharmaceuticals Ltd. severance costs for fiscal 2018 was $592.00K, a 4.04% increase from fiscal 2017.
- Foamix Pharmaceuticals Ltd. severance costs for fiscal 2017 was $569.00K, a 39.80% increase from fiscal 2016.
- Foamix Pharmaceuticals Ltd. severance costs for fiscal 2016 was $407.00K, a 110.88% increase from fiscal 2015.
| Period end | Severance Costs 12 month | Severance Costs 12 month as first filed |
|---|---|---|
| 2019-12-31 | $719.00K 10-K · filed 2020-03-12 | |
| 2018-12-31 | $592.00K 10-K · filed 2020-03-12 | |
| 2017-12-31 | $569.00K 10-K · filed 2020-03-12 | $374.00K 10-K · filed 2018-02-27 |
| 2016-12-31 | $407.00K 10-K · filed 2019-02-28 | $244.00K 20-F · filed 2017-02-21 |
| 2015-12-31 | $193.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $157.00K 20-F · filed 2017-02-21 | |
| 2013-12-31 | $70.00K 20-F · filed 2016-03-02 | |
| 2012-12-31 | $43.00K 20-F · filed 2015-03-17 |